As stated in the European Society Atherosclerosis (EAS) consensus, the focus of clinical diagnosis is on LDL-C levels and premature (before the age of 55 years in men and 60 years in women) coronary heart disease (CHD) in the family, and/or high LDL-C concentrations and/or genetic mutation for FH in a family member [4]. The gene discussed is FH; the disease is coronary artery disorder.